Award recordCONTRACT

EXACT SCIENCES CORPORATION

PIID 36C25721N0675· VHA· 257-NETWORK CONTRACT OFFICE 17 (36C257)· Q301 · REFERENCE LABORATORY TESTING· FY2021· $82,373 net obligations· UEI NGBXEJX5GLE9· WI

Description

DEOBLIGATION OF EXCESS FUNDS ONCOLOGY REFE LAB TESTING FOR NTX NORTH TEXAS DALLAS

Base award description: ONCOLOGY REFE LAB TESTING FOR NTX NORTH TEXAS DALLAS

First action · last action
2021-08-31 · 2025-12-23
Transactions
11
First transaction's obligation
$319,051
Base + all options value (sum of deltas)
$82,373
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D70053
NAICS
621511 · MEDICAL LABORATORIES

Modification chain · 11 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$319,051$0Base award · 2021-08-31 · this action $319,051 · running total $319,051Modification P00001 · 2022-06-23 · this action -$248,867 · running total $70,184Modification P00002 · 2022-08-31 · this action $0 · running total $70,184Modification P00003 · 2022-08-31 · this action $107,394 · running total $177,578Modification P00004 · 2022-10-24 · this action -$46,267 · running total $131,311Modification P00005 · 2023-01-31 · this action -$38,315 · running total $92,996Modification P00006 · 2023-08-02 · this action $69,139 · running total $162,135Modification P00007 · 2024-03-21 · this action -$45,163 · running total $116,973Modification P00008 · 2024-07-16 · this action $69,079 · running total $186,052Modification P00009 · 2024-12-17 · this action -$55,323 · running total $130,728Modification P00010 · 2025-12-23 · this action -$48,355 · running total $82,373
  • Base2021-08-31+$319,051= $319,051
  • Mod P000012022-06-23-$248,867= $70,184
  • Mod P000022022-08-31+$0= $70,184
  • Mod P000032022-08-31+$107,394= $177,578
  • Mod P000042022-10-24-$46,267= $131,311
  • Mod P000052023-01-31-$38,315= $92,996
  • Mod P000062023-08-02+$69,139= $162,135
  • Mod P000072024-03-21-$45,163= $116,973
  • Mod P000082024-07-16+$69,079= $186,052
  • Mod P000092024-12-17-$55,323= $130,728
  • Mod P000102025-12-23-$48,355= $82,373
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2021-08-31+$319,051$319,051ONCOLOGY REFE LAB TESTING FOR NTX NORTH TEXAS DALLAS
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-06-23−$248,867$70,184ONCOLOGY REFE LAB TESTING FOR NTX NORTH TEXAS DALLAS
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-08-31+$0$70,184ONCOLOGY REFE LAB TESTING FOR NTX NORTH TEXAS DALLAS
Mod P00003· EXERCISE AN OPTION2022-08-31+$107,394$177,578ONCOLOGY REFE LAB TESTING FOR NTX NORTH TEXAS DALLAS
Mod P00004· FUNDING ONLY ACTION2022-10-24−$46,267$131,311ONCOLOGY REFE LAB TESTING FOR NTX NORTH TEXAS DALLAS
Mod P00005· FUNDING ONLY ACTION2023-01-31−$38,315$92,996ONCOLOGY REFE LAB TESTING FOR NTX NORTH TEXAS DALLAS
Mod P00006· EXERCISE AN OPTION2023-08-02+$69,139$162,135ONCOLOGY REFE LAB TESTING FOR NTX NORTH TEXAS DALLAS
Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-03-21−$45,163$116,973ONCOLOGY REFE LAB TESTING FOR NTX NORTH TEXAS DALLAS
Mod P00008· EXERCISE AN OPTION2024-07-16+$69,079$186,052ONCOLOGY REFE LAB TESTING FOR NTX NORTH TEXAS DALLAS
Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-12-17−$55,323$130,728ONCOLOGY REFE LAB TESTING FOR NTX NORTH TEXAS DALLAS
Mod P00010· OTHER ADMINISTRATIVE ACTION2025-12-23−$48,355$82,373DEOBLIGATION OF EXCESS FUNDS ONCOLOGY REFE LAB TESTING FOR NTX NORTH TEXAS DALLAS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NGBXEJX5GLE9)

AwardOffice · PSC / listingNet obligationsFY
36C25726N0419257-NETWORK CONTRACT OFFICE 17 (36C257) · Q301 · REFERENCE LABORATORY TESTING$127,174FY2026
36C25726N0252257-NETWORK CONTRACT OFFICE 17 (36C257) · Q301 · REFERENCE LABORATORY TESTING$52,215FY2026
36C25526N0057255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING$3,454FY2026
36C25526N0054255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING$24,259FY2026
36C25526N0056255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING$3,454FY2026
36C25526N0055255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING$3,116FY2026

Other recipients under Q301 from 257-NETWORK CONTRACT OFFICE 17 (36C257) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25726N0415UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO257-NETWORK CONTRACT OFFICE 17 (36C257)$27,000FY2026
36C25726N0422PROPATH SERVICES, LLC257-NETWORK CONTRACT OFFICE 17 (36C257)$1,531,914FY2026
36C25726N0390NEOGENOMICS LABORATORIES, INC.257-NETWORK CONTRACT OFFICE 17 (36C257)$493,650FY2026
36C25726N0382BIODESIX, INC257-NETWORK CONTRACT OFFICE 17 (36C257)$40,696FY2026
36C25726A0026BIODESIX, INC257-NETWORK CONTRACT OFFICE 17 (36C257)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25721N0675_3600_V797D70053_3600 · retrieved 2026-09-26.